Yan et al. recently reported that autoantigenic drive may contribute to the genesis of a tumor resembling CD5+ B-CLL in mice expressing a transgene of TCL1 [41]. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.